Mark A. Jarosinski

5.0k total citations
26 papers, 945 citations indexed

About

Mark A. Jarosinski is a scholar working on Molecular Biology, Organic Chemistry and Surgery. According to data from OpenAlex, Mark A. Jarosinski has authored 26 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Organic Chemistry and 4 papers in Surgery. Recurrent topics in Mark A. Jarosinski's work include Chemical Synthesis and Analysis (8 papers), Pancreatic function and diabetes (4 papers) and Diabetes Management and Research (3 papers). Mark A. Jarosinski is often cited by papers focused on Chemical Synthesis and Analysis (8 papers), Pancreatic function and diabetes (4 papers) and Diabetes Management and Research (3 papers). Mark A. Jarosinski collaborates with scholars based in United States, Australia and Switzerland. Mark A. Jarosinski's co-authors include Victor J. Hruby, Guigen Li, Chuan‐Fa Liu, Wayne K. Anderson, Michael A. Weiss, Irvin S. Y. Chen, Juli Feigon, Elizabeth S. Withers-Ward, Thorsten Dieckmann and Balamurugan Dhayalan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Mark A. Jarosinski

26 papers receiving 914 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark A. Jarosinski United States	16	495	198	128	126	97	26	945
Róbert Kiss Hungary	22	618 1.2×	139 0.7×	25 0.2×	120 1.0×	119 1.2×	61	1.3k
Hiroki Tsumoto Japan	25	1.4k 2.7×	377 1.9×	66 0.5×	236 1.9×	163 1.7×	69	2.0k
Steven C. Koerber United States	22	690 1.4×	77 0.4×	40 0.3×	40 0.3×	78 0.8×	42	1.1k
María A. Frías Argentina	18	1.5k 3.0×	57 0.3×	32 0.3×	145 1.2×	93 1.0×	38	1.9k
Nicholas J. Bach United States	13	576 1.2×	285 1.4×	34 0.3×	57 0.5×	253 2.6×	31	1.1k
Taraneh Mirzadegan United States	16	660 1.3×	134 0.7×	15 0.1×	241 1.9×	60 0.6×	32	1.2k
C. Parthier Germany	18	798 1.6×	72 0.4×	94 0.7×	115 0.9×	135 1.4×	32	1.2k
Kilian W. Conde‐Frieboes Denmark	18	960 1.9×	258 1.3×	12 0.1×	189 1.5×	82 0.8×	33	1.4k
Bernard Cuenoud Switzerland	27	1.6k 3.2×	211 1.1×	37 0.3×	466 3.7×	127 1.3×	53	2.2k
Henri Mattes Switzerland	17	507 1.0×	247 1.2×	19 0.1×	60 0.5×	62 0.6×	29	915

Countries citing papers authored by Mark A. Jarosinski

Since Specialization

Citations

This map shows the geographic impact of Mark A. Jarosinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Jarosinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Jarosinski more than expected).

Fields of papers citing papers by Mark A. Jarosinski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Jarosinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Jarosinski. The network helps show where Mark A. Jarosinski may publish in the future.

Co-authorship network of co-authors of Mark A. Jarosinski

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Jarosinski. A scholar is included among the top collaborators of Mark A. Jarosinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Jarosinski. Mark A. Jarosinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dhayalan, Balamurugan, Michael D. Glidden, Alexander N. Zaykov, et al.. (2022). Peptide Model of the Mutant Proinsulin Syndrome. I. Design and Clinical Correlation. Frontiers in Endocrinology. 13. 821069–821069. 4 indexed citations

Jarosinski, Mark A., et al.. (2021). Structural principles of insulin formulation and analog design: A century of innovation. Molecular Metabolism. 52. 101325–101325. 19 indexed citations

Jarosinski, Mark A., et al.. (2021). ‘Smart’ insulin-delivery technologies and intrinsic glucose-responsive insulin analogues. Diabetologia. 64(5). 1016–1029. 59 indexed citations

Chen, Yen‐Shan, Yanwu Yang, Balamurugan Dhayalan, et al.. (2021). Insertion of a synthetic switch into insulin provides metabolite-dependent regulation of hormone–receptor activation. Proceedings of the National Academy of Sciences. 118(30). 14 indexed citations

Price-Troska, Tammy, Zhi‐Zhang Yang, David Diller, et al.. (2018). Inhibiting IL-2 signaling and the regulatory T-cell pathway using computationally designed peptides. Investigational New Drugs. 37(1). 9–16. 5 indexed citations

Diller, David, et al.. (2015). Rational, Computer-Enabled Peptide Drug Design: Principles, Methods, Applications and Future Directions. Future Medicinal Chemistry. 7(16). 2173–2193. 37 indexed citations

Fotsch, Christopher, D.M. Smith, Jeffrey A. Adams, et al.. (2003). Design of a new peptidomimetic agonist for the melanocortin receptors based on the solution structure of the peptide ligand, Ac-Nle-cyclo[Asp-Pro-dPhe-Arg-Trp-Lys]-NH2. Bioorganic & Medicinal Chemistry Letters. 13(14). 2337–2340. 37 indexed citations

Jarosinski, Mark A., et al.. (2003). Proteinase-activated receptor-2 mediates hyperresponsiveness in isolated guinea pig bronchi. Biochemical Pharmacology. 66(3). 519–525. 32 indexed citations

Bannon, Anthony W., et al.. (2001). Multiple Behavioral Effects of Cocaine- and Amphetamine-Regulated Transcript (CART) Peptides in Mice: CART 42–89 and CART 49–89 Differ in Potency and Activity. Journal of Pharmacology and Experimental Therapeutics. 299(3). 1021–1026. 53 indexed citations

10.

Biere, Anja Leona, Stephen Wood, Jette Wypych, et al.. (2000). Parkinson's Disease-associated α-Synuclein Is More Fibrillogenic than β- and γ-Synuclein and Cannot Cross-seed Its Homologs. Journal of Biological Chemistry. 275(44). 34574–34579. 151 indexed citations

11.

Harding, Brian J., et al.. (2000). A comparison of folding techniques in the chemical synthesis of the epidermal growth factor‐like domain in neu differentiation factor α/β. Journal of Peptide Research. 55(5). 359–371. 8 indexed citations

12.

Lee, Carolyn, Flavia Piazza, Inga Strehlow, et al.. (1999). Characterization of the Stat5 Protease. Journal of Biological Chemistry. 274(38). 26767–26775. 45 indexed citations

13.

Ettmayer, Peter, Dennis S. France, John Gounarides, et al.. (1999). Structural and Conformational Requirements for High-Affinity Binding to the SH2 Domain of Grb2. Journal of Medicinal Chemistry. 42(6). 971–980. 79 indexed citations

14.

Mayer, John P., et al.. (1998). Lanthionine macrocyclization by in situ activation of serine. Journal of Peptide Research. 51(6). 432–436. 30 indexed citations

15.

Dieckmann, Thorsten, Elizabeth S. Withers-Ward, Mark A. Jarosinski, et al.. (1998). Structure of a human DNA repair protein UBA domain that interacts with HIV-1 Vpr. Nature Structural Biology. 5(12). 1042–1047. 114 indexed citations

16.

Shapiro, Michael J., Jefferson Chin, Roger Martí, & Mark A. Jarosinski. (1997). Enhanced resolution in MAS NMR for combinatorial chemistry. Tetrahedron Letters. 38(8). 1333–1336. 43 indexed citations

17.

Jarosinski, Mark A., P. S. REDDY, & Wayne K. Anderson. (1993). Synthesis, chemical reactivity, and antitumor evaluation of congeners of carmethizole hydrochloride, an experimental acylated vinylogous carbinolamine tumor inhibitor. Journal of Medicinal Chemistry. 36(23). 3618–3627. 15 indexed citations

18.

Li, Guigen, Mark A. Jarosinski, & Victor J. Hruby. (1993). Diastereospecific tandem Michael-like addition / electrophilic bromination: A one-pot tandem asymmetric synthesis of precursors of unusual amino acids. Tetrahedron Letters. 34(16). 2561–2564. 59 indexed citations

19.

Li, Guigen, Keith C. Russell, Mark A. Jarosinski, & Victor J. Hruby. (1993). Asymmetric synthesis of unusual amino acids : An enantioselective synthesis of the four isomers of D- and L-O-Methyl-2′, β-Dimethyltyrosine. Tetrahedron Letters. 34(16). 2565–2568. 32 indexed citations

20.

Kinder, Frederick R., Mark A. Jarosinski, & Wayne K. Anderson. (1991). Synthesis of 3-pyrrolines by an intramolecular Wittig reaction. The Journal of Organic Chemistry. 56(22). 6475–6477. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact